BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23724143)

  • 1. Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer.
    Yan J; Wong N; Hung C; Chen WX; Tang D
    PLoS One; 2013; 8(5):e65463. PubMed ID: 23724143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.
    Zhang R; Yao W; Qian P; Li Y; Jiang C; Ao Z; Qian G; Wang C; Wu G; Li J; Ji F; Xu J
    Biomed Pharmacother; 2015 Apr; 71():172-84. PubMed ID: 25960233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH; Yu JW; Wu JG; Wang SL; Jiang BJ
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2109-20. PubMed ID: 25952582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of contactin-1 expression promotes prostate cancer progression.
    Wang B; Yang X; Zhao T; Du H; Wang T; Zhong S; Yang B; Li H
    Oncol Lett; 2020 Feb; 19(2):1611-1618. PubMed ID: 32002038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
    Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
    Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
    Xue F; Jia Y; Zhao J
    Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum starvation regulates E-cadherin upregulation via activation of c-Src in non-small-cell lung cancer A549 cells.
    Dong S; Khoo A; Wei J; Bowser RK; Weathington NM; Xiao S; Zhang L; Ma H; Zhao Y; Zhao J
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C893-9. PubMed ID: 25163517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.
    Yan J; Ojo D; Kapoor A; Lin X; Pinthus JH; Aziz T; Bismar TA; Wei F; Wong N; De Melo J; Cutz JC; Major P; Wood G; Peng H; Tang D
    Cancer Res; 2016 Mar; 76(6):1603-14. PubMed ID: 26795349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contactin-1 (CNTN-1) overexpression is correlated with advanced clinical stage and lymph node metastasis in oesophageal squamous cell carcinomas.
    Liu P; Chen S; Wu W; Liu B; Shen W; Wang F; He X; Zhang S
    Jpn J Clin Oncol; 2012 Jul; 42(7):612-8. PubMed ID: 22581910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells.
    Reddy P; Liu L; Ren C; Lindgren P; Boman K; Shen Y; Lundin E; Ottander U; Rytinki M; Liu K
    Mol Endocrinol; 2005 Oct; 19(10):2564-78. PubMed ID: 15928314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
    Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
    Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine kinase 1 enhances the invasion and migration of non-small cell lung cancer cells via the AKT pathway.
    Zhu L; Wang Z; Lin Y; Chen Z; Liu H; Chen Y; Wang N; Song X
    Oncol Rep; 2015 Mar; 33(3):1257-63. PubMed ID: 25529771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
    Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
    Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin.
    Zhou Q; Yan B; Hu X; Li XB; Zhang J; Fang J
    Mol Cancer Ther; 2009 Jun; 8(6):1684-91. PubMed ID: 19509250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.